SCHEMBL14743883

SCHEMBL14743883

COC(=O)c1ccc(NC(=O)c2ccncc2)c2c(Cl)cc(Cl)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.46
▸ MAPK10 P53779 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ KCNMA1 Q12791 1/20 0.46
▸ CHUK O15111 2/20 0.46
▸ ICOSLG O75144 2/20 0.46
▸ ICOS Q9Y6W8 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ LMNA P02545 3/20 0.46
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ PKM P14618 1/20 0.44
▸ TYK2 P29597 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ HPGD P15428 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ GAA P10253 1/20 0.43
▸ POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14743106 0.90 KDM4E (0.53) MAPK1HSD17B10SMN1; SMN2KDM4ELMNA
SCHEMBL14742996 0.78 KDM4E (0.49) MAPK1MAPK10HSD17B10SMN1; SMN2KCNMA1
SCHEMBL14743107 0.78 LMNA (0.49) MAPK1MAPK10HSD17B10SMN1; SMN2KCNMA1
SCHEMBL14743739 0.73 MEN1 (0.48) MAPK1HSD17B10SMN1; SMN2KDM4ELMNA
SCHEMBL14743884 0.72 RAB9A (0.39) SMN1; SMN2KDM4ELMNANPC1RAB9A
SCHEMBL204144 0.70 HSD17B10 (0.54) MAPK1MAPK10HSD17B10KDM4ELMNA
SCHEMBL417914 0.70 SERPINE1 (0.64) —
SCHEMBL3610020 0.69 KDM4C (0.55) MAPK1MAPK10HSD17B10SMN1; SMN2KDM4E
SCHEMBL14743672 0.69 KCNMA1 (0.50) MAPK1SMN1; SMN2KCNMA1CHUKICOSLG
SCHEMBL20897514 0.69 MAPK1 (0.56) MAPK1MAPK10HSD17B10KCNMA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013030358-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2013-03-07 — — WO disclosed
Send feedback